Clinical Trials on Active C. Difficile Colitis in New Zealand

Total 14 results

State University of New York at Buffalo

Withdrawn

Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy (c diff)

C. Difficile Infection

United States
Maimonides Medical Center

Completed

Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin

Clostridium Difficle Colitis | Clostridium Difficle Associated Disease

United States
Ferring Pharmaceuticals

Completed

Canadian Active & Maintenance Modified Pentasa Study (CAMMP)

Active Ulcerative Colitis | Remission of Ulcerative Colitis

Canada
Deinove

Recruiting

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

Clostridium Difficile (C. Difficile)

United States, Canada
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
Genzyme, a Sanofi Company

Completed

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Clostridium Difficile-Associated Diarrhea | Antibiotic-associated Diarrhea | Clostridium Enterocolitis | Clostridium Difficile Diarrhea | Antibiotic-associated Colitis

United States, Canada, United Kingdom, Puerto Rico
Memorial Sloan Kettering Cancer Center

Completed

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Cancer | C. Difficile Infection

United States
Stony Brook University

Completed

Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis (FMT)

Ulcerative Colitis | Clostridium Difficile Infection | Indeterminate Colitis

United States
Finch Research and Development LLC.

Terminated

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) (PRISM4)

Recurrent C. Difficile Infection

United States, Canada
AstraZeneca

Terminated

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Elevated High-sensitivity C-Reactive Protein (hsCRP)

United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more
Pfizer

Completed

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Hepatitis, Chronic Active

United States
Pfizer

Completed

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

Hepatitis, Chronic Active

United States
McMaster University

Completed

Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)

Infections | Diarrhea | Ventilator Associated Pneumonia | Antibiotic-associated Diarrhea | C-Difficile

Canada, United States, Saudi Arabia
The Touro College and University System
University of Vienna; Osato Research Institute; University of Mauritius; Mauritius... and other collaborators

Completed

Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases

Assess the Effect of Green Tea on Diabetes | Assess the Effect of Fermented Papaya Pretration on Diabetes | Effects of Green Tea and FPP on C-reactive Proteins | Effects of Green Tea and FPP of Lipid Profiles in Diabetes | Effect of Green Tea and FPP on Atheroma Formation

Austria, Mauritius, United States

Clinical Trials on Active C. Difficile Colitis in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations